SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Cardiovasc Diabetol. 2023;22(1):18.

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study.

, , , , , ,

제1저자 이소령, 안효정 · 교신저자 최의근

소속 (8)
  1. Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, 03080, Seoul, Republic of Korea.
  2. Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, 03080, Seoul, Republic of Korea. choiek17@snu.ac.kr.
  3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. choiek17@snu.ac.kr.
  4. Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
  5. Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
  6. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  7. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Chest & Heart Hospital, Liverpool, UK.
  8. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Abstract

BACKGROUND Patients with concurrent atrial fibrillation (AF) and diabetes mellitus (DM) [AF-DM] have a high risk of cardiovascular and diabetes-related complications, but are less engaged in a comprehensive treatment approach. We evaluated the association of early rhythm control (ERC), lifestyle modification (LSM), and a combination of ERC and LSM with cardiovascular or diabetes-related complication risk in patients with AF-DM (type 2).

METHODS From the National Health Information Database, 47,940 patients diagnosed with AF-DM in 2009-2016 were included. We defined ERC as rhythm control therapy within two years of AF diagnosis and LSM as adherence to ≥ 2 of the healthy behaviors among non-current smoking, non-drinking, and regular exercise. We compared the primary (ischemic stroke) and secondary (macro- and microvascular complications, glycemic emergency, and all-cause death) outcomes in four groups: non-ERC and non-LSM (group 1), LSM only (group 2), ERC only (group 3), and both ERC and LSM (group 4).

RESULTS Of total, 10,617 (22%), 26,730 (55.8%), 2,903 (6.1%), and 7,690 (16.0%) were classified into groups 1 to 4, in sequence. The mean duration from AF diagnosis to ERC was 25.6 ± 75.5 days. During 4.0 (interquartile range: 2.5-6.2) years' follow-up, groups 2 and 3 were associated with 23% and 33% lower risks of stroke than group 1, respectively. Group 4 was associated with the lowest risk of stroke: hazard ratio (HR) 0.58, 95% confidence interval (CI) 0.51-0.67, p < 0.001. Regarding secondary outcomes, the lowest risks were also observed in group 4; macro- and microvascular complications, glycemic emergency, and all-cause death had HRs (95% CIs) of 0.63 (0.56-0.70), 0.88 (0.82-0.94), 0.72 (0.62-0.84), and 0.80 (0.73-0.87), respectively, all p < 0.001.

CONCLUSIONS For AF-DM patients, ERC and LSM exert a synergistic effect in preventing cardiovascular and diabetes-related complications with the greatest lowered risk of stroke. A comprehensive treatment approach should be pursued in AF-DM patients.

© 2023. The Author(s).

Keywords

Atrial fibrillationDiabetes mellitusEarly rhythm controlLifestyle modification

Figures

Fig. 1
Fig. 1 Flow diagram of the study population. AF, atrial fibrillation, ESRD end-stage renal disease
Fig. 2
Fig. 2 The risks of the primary and secondary outcomes (A) in the early rhythm control group compared with those in the non-early rhythm control group, (B) in the lifestyle modification group compared with those in the non-lifestyle modification group, and (C) according to the combination of early rhythm control and lifestyle modification among patients with concurrent atrial fibrillation and diabetes. All p-values were < 0.05, except for * (p = 0.805). In panel (C), the numbered risks are the hazard ratios of group 4 compared with those of group 1. ERC early rhythm control, HR, hazard ratio, Cx complications, LSM lifestyle modification
Fig. 3
Fig. 3 Cumulative risks of the primary and secondary outcomes in patients with concurrent atrial fibrillation and diabetes according to the combination of early rhythm control and a healthy lifestyle: ERC early rhythm control; LSM lifestyle modification

그림 출처: PubMed Central 공개 논문 (PMC9887851)

Conflict of interest statement

The authors declare no competing interests. EKC: Research grants or speaking fees from Abbott, Bayer, BMS/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd., Medtronic, Samjinpharm, Seers Technology, and Skylabs. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No personal fees were received. The remaining authors have nothing to disclose.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
Cardiovascular diabetology · eISSN 1475-2840
전자 출판
2023-01-30
MeSH
Humans · Atrial Fibrillation* / diagnosis / epidemiology / therapy · Cohort Studies · Risk Factors · Prognosis · Diabetes Mellitus, Type 2* / complications · Stroke* / diagnosis / epidemiology / prevention & control · Diabetes Complications* / diagnosis / epidemiology / therapy · Healthy Lifestyle · Delivery of Health Care, Integrated* · Diabetes Mellitus* / diagnosis / epidemiology / therapy
연구비
NIEHS NIH HHS 27302C0028
참고문헌
48편